Optimi Health To Host MDMA Educational Quality Assurance
“Know Your Drug Candidate: Safeguarding Quality in Psychedelic Therapy” webinar set for Tuesday, February 13, 2024 at 2:00 p.m. PST...
Stay updated with breaking news from Se Opti. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
“Know Your Drug Candidate: Safeguarding Quality in Psychedelic Therapy” webinar set for Tuesday, February 13, 2024 at 2:00 p.m. PST...
VANCOUVER, British Columbia, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a leading end-to-end drug...
Expansion to be headlined by Purity Life Health Products, Amazon, and Holt Renfrew...
Optimi Health Corp . a Canadian-based company licensed by Health Canada to produce and supply natural, EU-GMP grade psilocybin and other psychedelic substances, most notably MDMA, is pleased to announce that in conjunction with ATMA Journey Centers the companies have confirmed their intent to proceed with a Phase I clinical trial application that will document the safety of the Optimi’s natural psilocybin biomass ...
Collaborative expertise a hallmark for future supply of natural psilocybin...